Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Howard Baker told me on the steps of the capital, at the time of the inaugural,
He said “Mr. President I want you to know I will be with you through thick.”
And I said “What about thin?”
He said “Welcome to Washington”
http://ronaldreaganquote.com/2012/11/president-reagans-humor-washington-d-c-loyalty/
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg) for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C) in adults . This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use (CHMP) in September.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58658-almirall
Aquí te digo Cómo hacer un artículo para posicionarse en Google. Con lo cual, si logras hacerlo, incrementarás las ventas de tu negocio / popularidad
http://sinergiaemprendedores.com/como-hacer-un-articulo/
The front of card having matte ivory paper material and designed in a very systematic manner. Looking of card reflect the beauty.
http://www.allweddingcards.com/cart/completecard.asp?code=C-0770
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Fire meets ice as storm-mage Khamsin Coruscate weds icy-eyed conqueror Wynter Atrialan in NY Times Bestselling author C.L. Wilson’s new epic fantasy romance from Avon. Selected by Publishers Weekly as one of this summer’s most anticipated reads.
“What an adventure this story is!” Night Owl Reviews
“Wilson pulls out all the stops in her long awaited return to epic romantic fantasy, with plenty of steamy sensuality and riveting action.” Publishers Weekly
“A truly magnificent adventure!” Romantic Times Magazine
Find out more at http://www.clwilson.com Fantasy and Romance
Texas Instruments (TI) (NASDAQ: TXN) today introduced the first all-in-one USB Type-C and USB Power Delivery (PD) controller, which integrates a port power switch and port data multiplexer. The TPS65982 USB PD controller is the only integrated circuit (IC) available that provides the full power path, operating as a Single- or Dual-Role Port and enabling a variety of host and device power implementations.
For applications requiring higher data rates, the TPS65982 can be combined with the 5.4-Gbps HD3SS460, the industry’s first USB Type-C cross-point switch. This solution enables USB connectors on either end of the cable to be flipped up or down, delivers power up to 100 W, and supports Alternate Modes to distribute video over DisplayPort from the host to the end device.
To view the multimedia news release visit
http://www.multivu.com/players/English/70647529-texas-instruments-usb-type-c/
Sullivan & Cromwell announces the launch of a multi-part video series designed to share insights from senior S&C lawyers on trends and issues impacting global financial institutions. The interviews are conducted by Lee Pacchia, Founder and CEO of Mimesis Law. In the first segment, Mitch Eitel, Managing Partner of the S&C Financial Services Group, discusses the appearance of shareholder activism in the sector, the psychology that affects the industry and burdens on financial institutions from a range of Dodd Frank changes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7542531-sullivan-cromwell/
